In a remarkable financial quarter, major companies like Apple, Amazon, and Eli Lilly have consistently exceeded analysts' earnings expectations. Apple reported a strong second quarter with an EPS of $2.01 and $111.2 billion in revenue, largely driven by iPhone sales. Eli Lilly experienced a 56% growth in total revenue, reaching $19.7 billion, primarily due to its popular GLP-1 drugs, prompting an increased full-year revenue forecast. Meanwhile, Roblox faced challenges, cutting its annual bookings forecast as it adapts to new safety initiatives, illustrating the varied performance within the tech landscape.
“Moderna · surpassed Wall Street estimates · first-quarter revenue · $311 million, versus $78 million in U.S. markets”
“Roku · raised its annual platform revenue forecast · advertisers will continue to spend · sending its shares up 10% in extended trading”
“Apple · reported its second quarter earnings · topping analysts’ estimates · earnings per share (EPS) of $2.01 on revenue of $111.2 billion”
“Moderna · surpassed Wall Street estimates for first-quarter revenue · $311 million · helped by better-than-expected sales of its COVID-19 vaccine in international markets”
“Roblox · cut its annual bookings forecast · lower than its earlier forecast of $8.28 billion to $8.55 billion · signal that new safety initiatives may impact user growth and spending”
“Roblox · expects fiscal 2026 bookings of · $7.33 billion to $7.6 billion · lower than its earlier forecast”
“Reddit · topped analysts’ estimates in its Q2 earnings report · strong quarterly revenue growth and advertiser demand · driven by its AI-powered advertising tools”
“Reddit's quarterly revenue forecast · exceeded the LSEG-compiled analysts' average estimate · $711.6 million · between $715 million to $725 million”
“Rivian · reported first quarter earnings results · that largely met expectations · as the pure-play EV maker navigates the launch of its highly anticipated R2 midsize SUV”
“Eli Lilly · stock soared by · 6% · after the pharmaceutical company reported strong sales for its GLP-1 drugs”
“Zepbound revenue · increased · 80% year over year · to $4.16 billion”
“Mounjaro revenue · soared · 125% · to $8.66 billion”
